4D Pharma PLC ADR (LBPS) Key Ratios

$1.65

$0.00 (0.00%)

As on 28-Jul-2022 09:30EDT

Market cap

info icon

$37 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

1.3

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- 34.46 -- --
EBIT 0.00 -41.14 -23.11 -4.07 -196.42
Net Profit -- -- -23.01 -13.29 -204.37
EPS -- -- -- -- --
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsDec-21Dec-20Dec-19
EBIT-Margin info -7,907.69-7,907.69-4,370.33-5,650.37-13,702.37
Net Margin info ----------
Return on equity info -93.22-69.99-105.78-103.21-70.67
Return on Capital info -84.83-70.81-86.03-98.94-69.51
Return on Assets info -68.09-52.91-67.80-78.64-57.84
Debt to Equity (x) info ----0.390.040.05
ROCE

-86.03

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Dec-21
Dec-20
Dec-19
Dec-18
Dec-17
4D Pharma PLC ADR (LBPS)
-86.03
-98.94
-69.51
-40.98
-58.56
Peer Median
--
--
--
--
--
ROE

-105.78

--

Profit after tax / Average Net worth * 100

Company Name
Dec-21
Dec-20
Dec-19
Dec-18
Dec-17
4D Pharma PLC ADR (LBPS)
-105.78
-103.21
-70.67
-41.00
-29.30
Peer Median
--
--
--
--
--
ROA

-67.80

--

Profit after tax / Average Total assets * 100

Company Name
Dec-21
Dec-20
Dec-19
Dec-18
Dec-17
4D Pharma PLC ADR (LBPS)
-67.80
-78.64
-57.84
-36.35
-23.93
Peer Median
--
--
--
--
--
EBIT Margin

-4,370.33

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Dec-21
Dec-20
Dec-19
Dec-18
Dec-17
4D Pharma PLC ADR (LBPS)
-4,370.33
-5,650.37
-13,702.37
--
--
Peer Median
--
--
--
--
--
Net Margin

-4,448.19

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Dec-21
Dec-20
Dec-19
Dec-18
Dec-17
4D Pharma PLC ADR (LBPS)
-4,448.19
-4,861.99
-11,405.69
--
--
Peer Median
--
--
--
--
--
Revenue Growth

0.34

--

Year on year growth in net sales

Company Name
Dec-21
Dec-20
Dec-19
Dec-18
Dec-17
4D Pharma PLC ADR (LBPS)
0.34
1.53
--
--
--
Peer Median
--
--
--
--
--
EBIT Growth

-4.00

--

Year on year growth in operating profit (EBIT)

Company Name
Dec-21
Dec-20
Dec-19
Dec-18
Dec-17
4D Pharma PLC ADR (LBPS)
-4.00
-4.36
-2.93
-38.30
-83.39
Peer Median
--
--
--
--
--
Net Profit Growth

-23.01

--

Year on year growth in profit after tax

Company Name
Dec-21
Dec-20
Dec-19
Dec-18
Dec-17
4D Pharma PLC ADR (LBPS)
-23.01
-7.88
-1.59
-15.87
-107.29
Peer Median
--
--
--
--
--
Debt to Equity

0.39

--

Total debt / Net worth

Company Name
Dec-21
Dec-20
Dec-19
Dec-18
Dec-17
4D Pharma PLC ADR (LBPS)
0.39
0.04
0.05
0.00
0.00
Peer Median
--
--
--
--
--
Short term debt to equity ratio

0.00

--

(Short term borrowings / Net worth)

Company Name
Dec-21
Dec-20
Dec-19
Dec-18
Dec-17
4D Pharma PLC ADR (LBPS)
0.00
0.00
0.00
0.00
0.00
Peer Median
--
--
--
--
--
Current Ratio

5.21

--

Current Assets / Current Liabilities and Provisions

Company Name
Dec-21
Dec-20
Dec-19
Dec-18
Dec-17
4D Pharma PLC ADR (LBPS)
5.21
2.59
1.80
6.40
11.60
Peer Median
--
--
--
--
--
Quick Ratio

5.16

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Dec-21
Dec-20
Dec-19
Dec-18
Dec-17
4D Pharma PLC ADR (LBPS)
5.16
2.55
1.77
6.35
11.55
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

407.33

--

Debtors outstanding / Net Sales * 100

Company Name
Dec-21
Dec-20
Dec-19
Dec-18
Dec-17
4D Pharma PLC ADR (LBPS)
407.33
1,135.21
2,901.42
--
--
Peer Median
--
--
--
--
--
Asset Turnover

0.02

--

Sales / Average Total Assets

Company Name
Dec-21
Dec-20
Dec-19
Dec-18
Dec-17
4D Pharma PLC ADR (LBPS)
0.02
0.02
0.01
--
--
Peer Median
--
--
--
--
--
Receivable days

2,285.78

--

Average Debtors / Sales * 365

Company Name
Dec-21
Dec-20
Dec-19
Dec-18
Dec-17
4D Pharma PLC ADR (LBPS)
2,285.78
4,166.86
9,966.48
--
--
Peer Median
--
--
--
--
--
loading...
loading...